Abiopharma

🔍 McEvoy Ashley (Director)

Company: INSULET CORP (PODD)

Report Date: 2026-08-21

Detailed Transactions and Holdings:

• Acquired 1,100 shares of Common Stock at $147.47 per share (Direct)
  Date: 2026-08-21 | Code: P | equity_swap_involved: 0 | shares_owned_after: 23,731.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-21 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 4.00

Footnotes:

• F1: The price reported represents the weighted average purchase price of the shares acquired. The shares were purchased in multiple transactions at prices ranging from $147.42 to $147.62. The Reporting Person hereby undertakes, upon the request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares purchased at each separate price.
• F2: Includes 80 shares acquired under the Insulet Corporation Employee Stock Purchase Plan since the date of the Reporting Person's last Form 4 filing.